PL EN


Preferences help
enabled [disable] Abstract
Number of results
2019 | 76 | 4 | 745-751
Article title

Safety of oral nifuroxazide – analysis of data from a spontaneous reporting system

Content
Title variants
Languages of publication
EN
Abstracts
EN
Nifuroxazide is a popular chemotherapeutic agent, that is widely used in Poland in acute and chronic bacterial diarrhea treatment. It is available in pharmacies as over-the-counter tablets for adults and a suspension on prescription for children. The aim of the study was to assess the safety of nifuroxazide therapy. Adverse reaction reports from the Regional Pharmacovigilance Center in Wroclaw, the pharmaceutical company PPF Hasco-Lek, and VigiAccess and EudraVigilance databases were analyzed. Based on the analysis of the data collected from the above sources, nifuroxazide have shown a high therapeutic value in the gastrointestinal tract infections, maintaining high safety of usage at the same time. The number of drug application adverse reactions in Poland is not so high primarily due to high safety profile and low patient awareness of the possibility of reporting drug side effects.
Year
Volume
76
Issue
4
Pages
745-751
Physical description
Dates
published
2019-08-30
References
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.doi-10_32383_appdr_105805
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.